检索分析平台:
1 中国检索平台 http://www.pubmedplus.cn/
2 德国检索平台 http://www.gopubmed.org/web/gopubmed/1?WEB013yge0vato9pyI9I1I00h001000d1002020000100100000011100040111
3 美国再研项目检索平台 https://vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta?v%3Aproject=hsrProj&query=diabetes+mellitus++AND+++++individualized+medicine
4 美国临床试验检索平台 https://clinicaltrials.gov/ct2/results?term=diabetes+mellitus++AND+++++individualized+medicine&Search=Search
检索策略:
("diabetes mellitus"[MeSH Terms] OR ("diabetes"[All Fields] AND "mellitus"[All Fields]) OR "diabetes mellitus"[All Fields]) AND ("individualized medicine"[MeSH Terms] OR ("individualized"[All Fields] AND "medicine"[All Fields]) OR "individualized medicine"[All Fields])
糖尿病个性化治疗研究论文454篇分布如下:
期刊影响因子10;H指数130以上的论文13篇如下:
01.上海交通大学医学院第六人民医院 1 篇0.220% 02.上海交通大学医学院附属新华医院 1 篇0.220% 07.天津中医药大学第一附属医院 1 篇0.220% 01.上海交通大学医学院第六人民医院.贾伟平 1 篇0.220% 02.上海交通大学医学院第六人民医院.陈海冰 1 篇0.220% 03.上海交通大学医学院附属新华医院.范建高 1 篇0.220% 08.北京大学第三医院.常翠青 1 篇0.220% 11.天津中医药大学第一附属医院.郭卉 1 篇0.220% 19.birmingham.uk 4 篇0.881% 02.blood glucose 109 篇24.009% 03.hemoglobin a, glycosylated 68 篇14.978% 05.hemoglobin a 64 篇14.097% 06.hemoglobins 64 篇14.097% 08.pancreatic hormones 62 篇13.656% 09.proinsulin 58 篇12.775% 10.cholesterol 28 篇6.167% 13.protease inhibitors 16 篇3.524% 14.hematologic agents 13 篇2.863% 15.lipid regulating agents 13 篇2.863% 16.glucagon-like peptide 1 12 篇2.643% 17.anticholesteremic agents 11 篇2.423% 18.hydroxymethylglutaryl-coa reductase inhibitors 11 篇2.423% 19.angiotensin-converting enzyme inhibitors 10 篇2.203% 20.dipeptidyl peptidase 4 10 篇2.203% 01.hypoglycemic agents 72 篇15.859% 02.blood glucose 60 篇13.216% 03.hemoglobin a, glycosylated 45 篇9.912% 05.hemoglobin a1c protein, human 18 篇3.965% 06.antihypertensive agents 10 篇2.203% 08.angiotensin-converting enzyme inhibitors 7 篇1.542% 09.biological markers 7 篇1.542% 10.anticoagulants 6 篇1.322% 12.dietary carbohydrates 6 篇1.322% 13.hydroxymethylglutaryl-coa reductase inhibitors 6 篇1.322% 15.cholesterol, ldl 5 篇1.101% 16.dipeptidyl-peptidase iv inhibitors 5 篇1.101% 17.platelet aggregation inhibitors 5 篇1.101% 18.cholesterol, hdl 4 篇0.881% 20.genetic markers 4 篇0.881% 02.rou dou kou yi 1 篇0.220% 03.shen jin cao 1 篇0.220% 18.女性泌尿生殖器疾病和妊娠并发症 38 篇8.370% 13.body weight problem 13 篇2.863% 01.department of medicine 64 篇14.097% 02.department of internal medicine 26 篇5.727% 03.division of endocrinology 19 篇4.185% 04.division of endocrinology and metabolism 9 篇1.982% 05.department of pediatrics 8 篇1.762% 06.school of medicine 8 篇1.762% 07.department of obstetrics and gynecology 6 篇1.322% 08.college of medicine 5 篇1.101% 09.department of endocrinology 5 篇1.101% 10.department of cardiovascular medicine 4 篇0.881% 11.department of clinical and experimental medicine 4 篇0.881% 12.department of surgery 4 篇0.881% 13.division of general internal medicine 4 篇0.881% 14.academic medical center 3 篇0.661% 15.department of family medicine 3 篇0.661% 16.department of genetics 3 篇0.661% 17.department of internal medicine ii 3 篇0.661% 18.department of neurology 3 篇0.661% 19.department of preventive medicine 3 篇0.661% 20.division of cardiovascular diseases 3 篇0.661% 01.eukaryota 385 篇84.802% 06.vertebrates 384 篇84.582% 07.haplorhini 383 篇84.361% 08.catarrhini 382 篇84.141% 09.hominidae 382 篇84.141% 18.gram-positive bacteria 3 篇0.661% 02.phosphorus 65 篇14.317% 04.cholesterol 28 篇6.167% 06.carbohydrate 12 篇2.643% 01.diabetes mellitus, type 2/drug therapy与hypoglycemic agents/therapeutic use 20 篇4.405% 02.diabetes mellitus, type 2/therapy与individualized medicine 7 篇1.542% 03.diabetes mellitus/drug therapy与insulin/therapeutic use 6 篇1.322% 04.hypoglycemic agents/therapeutic use与insulin/therapeutic use 6 篇1.322% 05.blood glucose/metabolism与hypoglycemic agents/therapeutic use 5 篇1.101% 06.cardiovascular diseases/prevention & control与diabetes mellitus, type 2/drug therapy 5 篇1.101% 07.diabetes mellitus, type 2/drug therapy与hyperglycemia/drug therapy 5 篇1.101% 08.blood glucose/metabolism与diabetes mellitus, type 2/drug therapy 4 篇0.881% 09.cardiovascular diseases/prevention & control与hypoglycemic agents/therapeutic use 4 篇0.881% 10.diabetes mellitus, type 1/drug therapy与diabetes mellitus, type 2/drug therapy 4 篇0.881% 11.diabetes mellitus, type 2/drug therapy与hypoglycemic agents/administration & dosage 4 篇0.881% 12.diabetes mellitus, type 2/therapy与obesity/therapy 4 篇0.881% 13.diabetes mellitus/drug therapy与hypoglycemic agents/therapeutic use 4 篇0.881% 14.hyperglycemia/drug therapy与hypoglycemic agents/therapeutic use 4 篇0.881% 15.antihypertensive agents/therapeutic use与hypertension/drug therapy 3 篇0.661% 16.blood glucose/drug effects与cardiovascular diseases/prevention & control 3 篇0.661% 17.blood glucose/drug effects与hypoglycemic agents/therapeutic use 3 篇0.661% 18.blood glucose/metabolism与diabetes mellitus, type 2/blood 3 篇0.661% 19.blood glucose/metabolism与hemoglobin a, glycosylated/metabolism 3 篇0.661% 20.cardiovascular diseases/epidemiology与diabetes mellitus, type 2/epidemiology 3 篇0.661% 01.北京大学第一医院与天津中医药大学第一附属医院合作 1 篇0.220%
United States 225 Germany 23 United Kingdom 21 Italy 18 Canada 16 Netherlands 15 Spain 12 Japan 11 South Korea 8 France 8 Australia 8 China 7 Switzerland 6 Czech Republic 6 Greece 5 Israel 4 Finland 4 South Africa 3 Denmark 3 Sweden 3 1 2 3
Saint Louis 13 Chicago 12 Boston 12 New York City 10 London 9 Baltimore 9 Seoul 8 Rochester 7 Amsterdam 7 Philadelphia 7 Seattle 6 Los Angeles 6 Praha 6 Durham 5 Paris 5 Atlanta 5 Minneapolis 5 Charlottesville 5 Montréal 4 Barcelona 4 1 2 3 ...12
Diabetes Care 15 Diabetes Technol Ther 11 J Diabetes Sci Technol 10 Diabet Med 8 Postgrad Med 7 Diabetes Res Clin Pract 6 Diab Vasc Dis Res 6 Nippon Rinsho 6 Diabetes Educ 6 Nutr Metab Cardiovasc Dis 5 Clin Geriatr Med 5 J Am Med Dir Assoc 4 Diabetes Ther 4 J Clin Endocrinol Metab 4 Circulation 4 Diabetes Metab Res Rev 4 Clin Ther 4 Diabetes Res Clin Pr 4 Hypertension 3 Am J Med 3 1 2 3 ...15
Cryer P 7 Hirsch I 5 Fonseca V 3 Associazione Medici Diabetologi 3 Chin M 3 Grossman E 2 Scheen A 2 Balakrishnan N 2 Leslie R 2 Klonoff D 2 Huang E 2 Cheung N 2 Ismail-Beigi F 2 Tuomilehto J 2 Grant R 2 Golubnitschaja O 2 Mooradian A 2 Kirk A 2 Mutrie N 2 Macintyre P 2 1 2 3 ...96
publications over time world map network of top authors
http://www.gopubmed.org/web/gopubmed/1?WEB013yge0vato9pyI9I1I00h001000d1002020000100100000011100040111
https://vsearch.nlm.nih.gov/vivisimo/cgi-bin/query-meta?v%3Aproject=hsrProj&query=diabetes+mellitus++AND+++++individualized+medicine
在研项目3项
http://medicine .yale.edu/intmed/endocrin/index.aspx
Investigator: Lipska, Kasia Joanna Performing Organization: Yale University, Yale School of Medicine , Department of Internal Medicine , Section of Endocrinology Supporting Agency: National Institutes of Health (NIH), National Institute on Aging (NIA) Project UI: 20141205 Project Status: Ongoing
http://medicine .uchicago.edu/gmed/index.html
Investigator: Huang, Elbert S Performing Organization: University of Chicago, Pritzker School of Medicine , Department of Medicine , Section of General Internal Medicine Supporting Agency: Agency for Healthcare Research and Quality (AHRQ) Project UI: 20124051 Project Status: Ongoing
Diabetes Mellitus / therapy
Investigator: Long, Judith Performing Organization: University of Pennsylvania, Perelman School of Medicine , Department of Medicine , Division of General Internal Medicine Supporting Agency: Patient-Centered Outcomes Research Institute (PCORI) Project UI: 20152039 Project Status: Ongoing
临床试验74项
https://clinicaltrials.gov/ct2/results/browse?term=diabetes+mellitus++AND+++++individualized+medicine&brwse=cond_alpha_all
转载本文请联系原作者获取授权,同时请注明本文来自许培扬科学网博客。 链接地址: https://blog.sciencenet.cn/blog-280034-882458.html
上一篇:
2015(第二届)代谢与疾病多学科研究论坛 下一篇:
BMC撤销论文处理动态 四川3个医院4篇